Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The recombinant kringle domain of urokinase plasminogen activator inhibits in vivo malignant glioma growth.
Kim CK, Hong SH, Joe YA, Shim BS, Lee SK, Hong YK. Kim CK, et al. Among authors: joe ya. Cancer Sci. 2007 Feb;98(2):253-8. doi: 10.1111/j.1349-7006.2006.00378.x. Cancer Sci. 2007. PMID: 17233842
Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3.
Joe YA, Hong YK, Chung DS, Yang YJ, Kang JK, Lee YS, Chang SI, You WK, Lee H, Chung SI. Joe YA, et al. Int J Cancer. 1999 Aug 27;82(5):694-9. doi: 10.1002/(sici)1097-0215(19990827)82:5<694::aid-ijc12>;2-c. Int J Cancer. 1999. PMID: 10417767
Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H, Kim HK, Lee JH, You WK, Chung SI, Chang SI, Park MH, Hong YK, Joe YA. Lee H, et al. Among authors: joe ya. Arch Biochem Biophys. 2000 Mar 15;375(2):359-63. doi: 10.1006/abbi.1999.1675. Arch Biochem Biophys. 2000. PMID: 10700393
Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.
Hong YK, Joe YA, Yang YJ, Lee KS, Son BC, Jeun SS, Chung DS, Cho KK, Park CK, Kim MC, Kim HK, Yung WK, Kang JK. Hong YK, et al. Among authors: joe ya. J Korean Med Sci. 2000 Jun;15(3):315-22. doi: 10.3346/jkms.2000.15.3.315. J Korean Med Sci. 2000. PMID: 10895975 Free PMC article.
Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development.
Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK. Hong YK, et al. Among authors: joe ya. Clin Cancer Res. 2000 Aug;6(8):3354-60. Clin Cancer Res. 2000. PMID: 10955823
Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas.
Kim IA, Yang YJ, Yoon SC, Choi IB, Kay CS, Kwon HC, Kim CM, Joe YA, Kang JK, Hong YK. Kim IA, et al. Among authors: joe ya. Int J Oncol. 2001 Nov;19(5):1041-7. doi: 10.3892/ijo.19.5.1041. Int J Oncol. 2001. PMID: 11605007
Effect of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on endothelial cell growth, differentiation and apoptosis.
Lee Y, Kim HK, Park HE, Park MH, Joe YA. Lee Y, et al. Among authors: joe ya. Mol Cell Biochem. 2002 Aug;237(1-2):69-76. doi: 10.1023/a:1016535217038. Mol Cell Biochem. 2002. PMID: 12236588
Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells.
Kim KS, Hong YK, Joe YA, Lee Y, Shin JY, Park HE, Lee IH, Lee SY, Kang DK, Chang SI, Chung SI. Kim KS, et al. Among authors: joe ya. J Biol Chem. 2003 Mar 28;278(13):11449-56. doi: 10.1074/jbc.M212358200. Epub 2003 Jan 15. J Biol Chem. 2003. PMID: 12529357
Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator.
Kim HK, Lee SY, Oh HK, Kang BH, Ku HJ, Lee Y, Shin JY, Hong YK, Joe YA. Kim HK, et al. Among authors: joe ya. Biochem Biophys Res Commun. 2003 May 16;304(4):740-6. doi: 10.1016/s0006-291x(03)00656-9. Biochem Biophys Res Commun. 2003. PMID: 12727218
Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases.
Kim JS, Yu HK, Ahn JH, Lee HJ, Hong SW, Jung KH, Chang SI, Hong YK, Joe YA, Byun SM, Lee SK, Chung SI, Yoon Y. Kim JS, et al. Among authors: joe ya. Biochem Biophys Res Commun. 2004 Jan 16;313(3):534-40. doi: 10.1016/j.bbrc.2003.11.148. Biochem Biophys Res Commun. 2004. PMID: 14697222
54 results
Jump to page